Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Exploring Undervalued Stocks On SEHK With Intrinsic Discounts Ranging From 32.2% To 47.7%

In This Article:

Amidst a backdrop of mixed economic signals from China, where industrial production has slowed and retail sales have seen an uptick, investors might find potential opportunities in undervalued stocks on the SEHK. These market conditions suggest that discerning investors could benefit from examining intrinsic discounts that reflect deeper value than current market prices indicate.

Top 10 Undervalued Stocks Based On Cash Flows In Hong Kong

Name

Current Price

Fair Value (Est)

Discount (Est)

Best Pacific International Holdings (SEHK:2111)

HK$2.09

HK$3.82

45.2%

China Resources Mixc Lifestyle Services (SEHK:1209)

HK$25.90

HK$46.07

43.8%

China Cinda Asset Management (SEHK:1359)

HK$0.71

HK$1.29

45%

Super Hi International Holding (SEHK:9658)

HK$13.48

HK$25.69

47.5%

Zylox-Tonbridge Medical Technology (SEHK:2190)

HK$9.99

HK$19.07

47.6%

Innovent Biologics (SEHK:1801)

HK$37.30

HK$66.87

44.2%

REPT BATTERO Energy (SEHK:666)

HK$14.26

HK$27.24

47.7%

Zhaojin Mining Industry (SEHK:1818)

HK$13.64

HK$25.10

45.7%

CGN Mining (SEHK:1164)

HK$2.66

HK$4.86

45.3%

Vobile Group (SEHK:3738)

HK$1.19

HK$2.11

43.6%

Click here to see the full list of 41 stocks from our Undervalued SEHK Stocks Based On Cash Flows screener.

We're going to check out a few of the best picks from our screener tool

Pacific Textiles Holdings

Overview: Pacific Textiles Holdings Limited is engaged in the manufacturing and trading of textile products, with a market capitalization of approximately HK$2.15 billion.

Operations: The company generates its revenue primarily from the production and sale of textiles, totaling approximately HK$4.55 billion.

Estimated Discount To Fair Value: 32.2%

Pacific Textiles Holdings, priced at HK$1.56, is trading below its fair value of HK$2.3, reflecting a 32.2% undervaluation based on discounted cash flows. Despite this potential bargain, the company's recent earnings guidance predicts a significant profit drop to HK$105.9 million for FY2024, a decrease of about 60%. Additionally, while earnings are expected to grow by 33.7% annually, this growth is shadowed by low return on equity forecasts and profit margins that have declined from last year's figures.

SEHK:1382 Discounted Cash Flow as at Jun 2024
SEHK:1382 Discounted Cash Flow as at Jun 2024

Shanghai INT Medical Instruments

Overview: Shanghai INT Medical Instruments Co., Ltd. is a company that specializes in the production and distribution of medical instruments, with a market capitalization of approximately HK$4.73 billion.